SCHEMBL6724701

SCHEMBL6724701

O=C(Nc1ccccn1)c1c[nH]c2ccc(OCCN3CCCC3)nc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.48
HTR1A P08908 4/20 0.44
HTR1F P30939 4/20 0.44
HTR1B P28222 3/20 0.44
HTR1D P28221 2/20 0.44
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
THPO P40225 1/20 0.42
PIM1 P11309 1/20 0.42
PIM2 Q9P1W9 1/20 0.42
PMP22 Q01453 1/20 0.42
DRD3 P35462 2/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
LTA4H P09960 1/20 0.39
PTGS2 P35354 1/20 0.39
WNT1 P04628 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6724794 0.95 MET (0.53) METHTR1AHTR1FHTR1BHTR1D
SCHEMBL6734018 0.94 MET (0.51) METHTR1AHTR1FHTR1BHTR1D
SCHEMBL6724792 0.93 HTR1A (0.49) METHTR1AHTR1FHTR1BHTR1D
SCHEMBL6726989 0.92 TEC (0.44) METHTR1AHTR1FHTR1BHTR1D
SCHEMBL6726991 0.88 HTR1A (0.48) METHTR1AHTR1FHTR1BHTR1D
SCHEMBL6733766 0.88 MET (0.46) METHTR1AHTR1FHTR1BHTR1D
SCHEMBL6724797 0.85 KDM4E (0.46) METHTR1AHTR1FHTR1BHTR1D
SCHEMBL6722238 0.85 HTR1A (0.47) METHTR1AHTR1FHTR1BHTR1D
SCHEMBL6722076 0.85 MEN1 (0.42) METHTR1AHTR1FHTR1BHTR1D
SCHEMBL6722035 0.84 HTR2C (0.44) HTR1AHTR1FHTR1BHTR1DALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US disclosed